ReviewJournal of inflammation research2018

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.

Danielle M Dunlea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.